Analyst picks & changes

Amgen Inc.

(AMGN), Thousand Oaks, Calif.

Business: Hematology

Vector Securities International analysts Barbara Hoffman and Michael King said they don't expect the proposed National Kidney Foundation's Dialysis Outcomes Quality Initiative (DOQI) guidelines to have any near-term impact on AMGN's

Read the full 409 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE